| QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
| Title of each class |
Trading Symbols |
Name of each exchange on which registered | ||
one-third of one redeemable warrant |
The | |||
The | ||||
The |
| Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
| Emerging growth company | ||||||
Page |
||||
| 1 | ||||
| 1 | ||||
| 2 | ||||
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 15 | ||||
| 17 | ||||
| 17 | ||||
| 18 | ||||
| 18 | ||||
| 19 | ||||
| 19 | ||||
| 19 | ||||
| 19 | ||||
| 20 | ||||
| 21 | ||||
September 30, 2021 |
December 31, 2020 |
|||||||
| (unaudited) | ||||||||
| ASSETS |
||||||||
| Current assets |
||||||||
| Cash |
$ | $ | — | |||||
| Prepaid expenses and other current assets |
— | |||||||
| |
|
|
|
|||||
| Total Current Assets |
— | |||||||
| Deferred offering costs |
— | |||||||
| Investments held in Trust Account |
— | |||||||
| |
|
|
|
|||||
| TOTAL ASSETS |
$ |
$ |
||||||
| |
|
|
|
|||||
| LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY |
||||||||
| Current liabilities |
||||||||
| Accrued expenses |
$ | $ | — | |||||
| Accrued offering costs |
— | |||||||
| Promissory note – related party |
— | |||||||
| |
|
|
|
|||||
| Total Current Liabilities |
||||||||
| Deferred underwriting fee payable |
— | |||||||
| Warrant liabilities |
— | |||||||
| |
|
|
|
|||||
| Total Liabilities |
||||||||
| Commitments and Contingencies |
||||||||
| Class A ordinary shares subject to possible redemption |
— | |||||||
| Shareholders’ (Deficit) Equity |
||||||||
| Preference shares, $ |
— | |||||||
| Class A ordinary shares, $ |
|
|
|
|
|
|
— |
|
| Class B ordinary shares, $ |
||||||||
| Additional paid-in capital |
— | |||||||
| Accumulated deficit |
( |
) | ( |
) | ||||
| |
|
|
|
|||||
| Total Shareholders’ (Deficit) Equity |
( |
) |
||||||
| |
|
|
|
|||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ (DEFICIT) EQUITY |
$ |
$ |
||||||
| |
|
|
|
|||||
Three Months Ended September 30, 2021 |
Nine Months Ended September 30, 2021 |
For the Period from August 31, 2020 (Inception) through September 30, 2020 |
||||||||||
| General and administrative expenses |
$ | $ | $ | |||||||||
| |
|
|
|
|
|
|||||||
| Loss from operations |
( |
) |
( |
) |
( |
) | ||||||
| Other income (expense): |
||||||||||||
| Income earned on investments held in Trust Account |
— | |||||||||||
| Interest expense |
( |
) | ( |
) | — | |||||||
| Transaction costs allocated to warrant liabilities |
|
|
— |
|
|
|
( |
) |
|
|
— |
|
| Change in fair value of warrant liabilities |
— | |||||||||||
| |
|
|
|
|
|
|||||||
| Total other income, net |
— | |||||||||||
| |
|
|
|
|
|
|||||||
| Net income (loss) |
$ |
$ |
$ |
( |
) | |||||||
| |
|
|
|
|
|
|||||||
| Weighted average shares outstanding, Class A ordinary shares |
— | |||||||||||
| |
|
|
|
|
|
|||||||
| Basic and diluted net income per share, Class A ordinary shares |
$ |
$ |
$ |
|||||||||
| |
|
|
|
|
|
|||||||
| Basic weighted average shares outstanding, Class B ordinary shares |
||||||||||||
| |
|
|
|
|
|
|||||||
| Basic net income (loss) per share, Class B ordinary shares |
$ |
$ |
$ |
( |
) | |||||||
| |
|
|
|
|
|
|||||||
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ (Deficit) Equity |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
| Balance — January 1, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||||
| Cash paid in excess of fair value of Private Placement warrants |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
| Accretion for Class A ordinary shares to redemption amount |
— |
— |
— |
— |
( |
) | ( |
) | ( |
) | ||||||||||||||||||
| Net income |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance – March 31, 2021 |
$ |
$ |
$ |
$ |
( |
) | $ |
( |
) | |||||||||||||||||||
| Net loss |
— |
— |
— |
— |
— |
( |
) | ( |
) | |||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance – June 30, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
| Net income |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance – September 30, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Class A Ordinary Shares |
Class B Ordinary Shares |
Additional Paid-in Capital |
Accumulated Deficit |
Total Shareholders’ Equity |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
| Balance — August 31, 2020 (Inception) |
$ |
$ | $ | $ | $ | |||||||||||||||||||||||
| Issuance of Class B ordinary shares |
— | — | — | |||||||||||||||||||||||||
| Net loss |
— | — | — | — | — | ( |
) | ( |
) | |||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
| Balance – September 30, 2020 |
$ |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Nine Months Ended September 30, 2021 |
For the Period from August 31, 2020 (Inception) through September 30, 2020 |
|||||||
| Cash Flows from Operating Activities: |
||||||||
| Net income (loss) |
$ | $ | ( |
) | ||||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: |
||||||||
| Payment of formation costs through issuance of Class B ordinary shares |
|
|
— |
|
|
|
|
|
| Income earned on investments held in Trust Account |
( |
) | — | |||||
| Change in fair value of warrant liabilities |
( |
) | — | |||||
| Transaction costs related to warrant liabilities |
— | |||||||
| Changes in operating assets and liabilities: |
||||||||
| Prepaid expenses and other current assets |
( |
) | — | |||||
| Accrued expenses |
— | |||||||
| |
|
|
|
|||||
| Net cash used in operating activities |
( |
) | — | |||||
| |
|
|
|
|||||
| Cash Flows from Investing Activities: |
||||||||
| Investment of cash into Trust Account |
( |
) | — | |||||
| |
|
|
|
|||||
| Net cash used in investing activities |
( |
) |
— |
|||||
| Cash Flows from Financing Activities: |
||||||||
| Proceeds from sale of Units, net of underwriting discounts paid |
— | |||||||
| Proceeds from sale of Private Placement Warrants |
— | |||||||
| Repayment of promissory note - related party |
( |
) | — | |||||
| Payment of offering costs |
( |
) | — | |||||
| |
|
|
|
|||||
| Net cash provided by financing activities |
— | |||||||
| Net Change in Cash |
— | |||||||
| Cash – Beginning |
— | |||||||
| |
|
|
|
|||||
| Cash – Ending |
$ |
$ | — | |||||
| |
|
|
|
|||||
| Non-cash investing and financing activities: |
||||||||
| Deferred underwriting fee payable |
$ | $ | — | |||||
| |
|
|
|
|
|
|
|
|
| Deferred offering costs included in accrued offering costs |
|
$ |
— |
|
|
$ |
|
|
| |
|
|
|
|
|
|
|
|
| Deferred offering costs paid through promissory note - related party |
|
$ |
— |
|
|
$ |
|
|
| |
|
|
|
|
|
|
|
|
| Deferred offering costs paid by Sponsor in exchange for the issuance of Class B ordinary shares |
|
$ |
— |
|
|
$ |
|
|
| |
|
|
|
|||||
Balance Sheet as of January 22, 2021 (audited) |
As Previously Reported |
Adjustment |
As Revised |
|||||||||
| Class A ordinary shares subject to possible redemption |
$ | $ | $ | |||||||||
| Class A ordinary shares |
$ | $ | ( |
) | $ | — | ||||||
| Additional paid-in capital |
$ | $ | ( |
) | $ | — | ||||||
| Accumulated deficit |
$ | ( |
) | $ | ( |
) | $ | ( |
) | |||
| Total Shareholders’ (Deficit) Equity |
$ | $ | ( |
) | $ | ( |
) | |||||
| Gross proceeds |
$ | |||
| Less: |
||||
| Proceeds allocated to Public Warrants |
( |
) | ||
| Class A ordinary shares issuance costs |
( |
) | ||
| Plus: |
||||
| Accretion of carrying value to redemption value |
||||
| |
|
|||
| Class A ordinary shares subject to possible redemption |
$ | |||
| |
|
Three Months Ended September 30, 2021 |
Nine Months Ended September 30, 2021 |
For the Period From August 31, 2020 (Inception) Through September 30, 2020 |
||||||||||||||||||||||
Class A |
Class B |
Class A |
Class B |
Class A |
Class B |
|||||||||||||||||||
| Basic and diluted net income (loss) per ordinary share |
||||||||||||||||||||||||
| Numerator: |
||||||||||||||||||||||||
| Allocation of net income (loss), as adjusted |
$ | $ | $ | $ | $ | $ | ( |
) | ||||||||||||||||
| Denominator: |
||||||||||||||||||||||||
| Basic and diluted weighted average shares outstanding |
||||||||||||||||||||||||
| |
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
| Basic and diluted net income (loss) per ordinary share |
$ | $ | $ | $ | $ | $ | ( |
) | ||||||||||||||||
| • | in whole and not in part; |
| • | at a price of $0.01 per warrant; |
| • | upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and |
| • | if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders. |
| • | in whole and not in part; |
| • | at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined based on the redemption date and the fair market value of the Class A ordinary shares; |
| • | if, and only if, the closing price of the Class A ordinary shares equal or exceeds $10.00 per public share (as adjusted) for any 20 trading days within the 30-trading day period ending three trading days before the Company sends the notice of redemption of the warrant holders; and |
| • | if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders is less than $18.00 per share (as adjusted), the Private Placement Warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above. |
Level 1: |
Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. | |||
Level 2: |
Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. | |||
Level 3: |
Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. | |||
Level |
Fair Value |
|||||||||
| Assets: |
||||||||||
| September 30, 2021 |
Investment held in Trust Account - Money Market Fund |
1 |
$ |
|||||||
| Liabilities: |
||||||||||
| September 30, 2021 |
Warrant Liability – Public Warrants |
1 |
||||||||
| September 30, 2021 |
Warrant Liability – Private Placement Warrants |
2 |
||||||||
| * | Filed herewith. |
| TZP STRATEGIES ACQUISITION CORP. | ||||||
| Date: November 12, 2021 | By: | /s/ Samuel Katz | ||||
| Name: | Samuel Katz | |||||
| Title: | Chief Executive Officer and Director | |||||
| (Principal Executive Officer) | ||||||
| Date: November 12, 2021 | By: | /s/ Sheera Michael | ||||
| Name: | Sheera Michael | |||||
| Title: | (Principal Financial Officer and | |||||
| Principal Accounting Officer) | ||||||